DK1242436T3 - Oligosaccharidblanding - Google Patents

Oligosaccharidblanding

Info

Publication number
DK1242436T3
DK1242436T3 DK00983244T DK00983244T DK1242436T3 DK 1242436 T3 DK1242436 T3 DK 1242436T3 DK 00983244 T DK00983244 T DK 00983244T DK 00983244 T DK00983244 T DK 00983244T DK 1242436 T3 DK1242436 T3 DK 1242436T3
Authority
DK
Denmark
Prior art keywords
oligosaccharides
oligosaccharide
extracted
animal
oligosaccharide mixture
Prior art date
Application number
DK00983244T
Other languages
English (en)
Inventor
Gilda Georgi
Bernd Stahl
Guenther Boehm
Berndt Finke
Juergen Jelinek
Joachim J Schmitt
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7931729&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1242436(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia Nv filed Critical Nutricia Nv
Application granted granted Critical
Publication of DK1242436T3 publication Critical patent/DK1242436T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20Milk; Whey; Colostrum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Fodder In General (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Materials For Medical Uses (AREA)
DK00983244T 1999-12-07 2000-12-07 Oligosaccharidblanding DK1242436T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19958985A DE19958985A1 (de) 1999-12-07 1999-12-07 Oligosaccharidmischung
PCT/EP2000/012345 WO2001042263A2 (de) 1999-12-07 2000-12-07 Oligosaccharidmischung

Publications (1)

Publication Number Publication Date
DK1242436T3 true DK1242436T3 (da) 2005-03-14

Family

ID=7931729

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00983244T DK1242436T3 (da) 1999-12-07 2000-12-07 Oligosaccharidblanding

Country Status (20)

Country Link
US (1) US7939118B2 (da)
EP (1) EP1242436B1 (da)
JP (1) JP2003516412A (da)
CN (1) CN1198624C (da)
AT (1) ATE282626T1 (da)
AU (1) AU782623B2 (da)
BR (1) BR0016161A (da)
CA (1) CA2394090C (da)
CZ (1) CZ304817B6 (da)
DE (2) DE19958985A1 (da)
DK (1) DK1242436T3 (da)
ES (1) ES2233485T3 (da)
HK (1) HK1052438B (da)
HU (1) HUP0203707A3 (da)
MX (1) MXPA02005491A (da)
NO (1) NO330050B1 (da)
NZ (1) NZ519706A (da)
PL (1) PL356238A1 (da)
PT (1) PT1242436E (da)
WO (1) WO2001042263A2 (da)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1243273A1 (en) 2001-03-22 2002-09-25 Societe Des Produits Nestle S.A. Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters
NZ515869A (en) * 2001-11-30 2003-09-26 Med Chem Ingredients Ltd Compositions and methods for animal treatment comprising gluco- and isomalto- oligosaccharides
CA2574721C (en) * 2004-07-19 2011-06-07 Life Science Nutrition As Ngna compositions and methods of use
US20080126195A1 (en) 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
EP1634599A1 (en) 2004-08-20 2006-03-15 N.V. Nutricia Iimmune stimulatory infant nutrition
ES2781328T3 (es) 2005-02-21 2020-09-01 Nestle Sa Mezcla de oligosacáridos
US7572474B2 (en) 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8287931B2 (en) * 2005-06-30 2012-10-16 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
US8075934B2 (en) * 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
RU2430631C2 (ru) 2006-02-10 2011-10-10 Нестек С.А. Пребиотическая смесь олигосахаридов и пищевой продукт, ее содержащий
RU2448720C2 (ru) * 2006-03-07 2012-04-27 Нестек С.А. Синбиотическая смесь
WO2007114683A1 (en) * 2006-03-30 2007-10-11 N.V. Nutricia Milk oligosaccharides for stimulating the immune system
EP1974743A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
US20100196539A1 (en) * 2007-06-25 2010-08-05 Albertus Alard Van Dijk Novel prebiotics
PT2217246E (pt) * 2007-11-08 2015-02-10 Nestec Sa Utilização de oligossacáridos contendo n-acetil-lactosamina para maturação de respostas imunes em recém-nascidos
EP2143341A1 (en) 2008-07-08 2010-01-13 Nestec S.A. Nutritional Composition Containing Oligosaccharide Mixture
US8986769B2 (en) * 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
US20100119558A1 (en) 2008-11-10 2010-05-13 Scandivir Ab Ngna compositions and methods of use
ES2527959T3 (es) * 2008-12-02 2015-02-02 Prolacta Bioscience, Inc. Composiciones de permeado de leche humana y métodos para realizarlas y usarlas
US8425955B2 (en) 2009-02-12 2013-04-23 Mead Johnson Nutrition Company Nutritional composition with prebiotic component
SG2014014435A (en) 2009-02-24 2014-07-30 Ritter Pharmaceuticals Inc Prebiotic formulations and methods of use
US8785160B2 (en) 2009-02-24 2014-07-22 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US8293264B2 (en) * 2009-05-11 2012-10-23 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
AU2015306339A1 (en) 2014-08-18 2016-12-15 Société des Produits Nestlé S.A. Prebiotics for reducing the risk of obesity later in life
EP2455387A1 (en) 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
SG191799A1 (en) 2010-12-31 2013-08-30 Abbott Lab Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof
SG10201707519PA (en) 2010-12-31 2017-10-30 Abbott Lab Neutral human milk oligosaccharides to promote growth of beneficial bacteria
EP2658546B1 (en) 2010-12-31 2018-12-05 Abbott Laboratories Methods of using human milk oligosaccharides for improving airway respiratory health
NZ612105A (en) 2010-12-31 2015-02-27 Abbott Lab Human milk oligosaccharides for modulating inflammation
BR112013016606A2 (pt) 2010-12-31 2016-09-27 Abbott Lab processos para redução de incidência de tensão oxidante usando oligossacarídeos de leite humano, vitamina c e agentes antiflamatórios
WO2012092156A1 (en) 2010-12-31 2012-07-05 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
BR112013015951A2 (pt) 2010-12-31 2018-07-10 Abbott Lab composições nutricionais compreendendo oligossacarídeos e nucleotídeos de leite humano e usos destas para tratar e/ou prevenir infecção viral entérica.
AU2012251422B2 (en) * 2011-05-05 2015-05-21 Life Science Nutrition As Performance enhancing compositions and methods of use
EP2526784A1 (en) * 2011-05-24 2012-11-28 Nestec S.A. Milk oligosaccharide-galactooligosaccharide composition for infant formula containing the soluble oligosaccharide fraction present in milk, and having a low level of monosaccharides, and a process to produce the composition
US10639319B2 (en) 2011-08-29 2020-05-05 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
EP3082473A2 (en) 2013-12-19 2016-10-26 Nestec S.A. Nutritional composition to reduce metabolic stress in infants
JP6058223B2 (ja) * 2015-01-20 2017-01-11 株式会社明治 リン吸収抑制用組成物
ES2971093T3 (es) * 2015-03-31 2024-06-03 Glycom As Mezclas de oligosacáridos de la leche humana que comprenden 3'-O-sialilactosa
US10933097B1 (en) 2020-03-05 2021-03-02 King Saud University Method of treating a bacterial infection using colostrum

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4859488A (en) 1987-09-15 1989-08-22 Kabushiki Kaisha Yakult Honsha Liquid food for curing constipation: polydextrose and oligosaccharide
JP2518663B2 (ja) * 1987-12-24 1996-07-24 株式会社ヤクルト本社 ガラクトオリゴ糖含有加工乳の製造法
US5750176A (en) * 1994-03-09 1998-05-12 Abbott Laboratories Transgenic non-human mammal milk comprising 2'-fucosyl-lactose
DE19701382A1 (de) * 1997-01-16 1998-07-23 Nutricia Nv Kohlenhydratmischung
US6045854A (en) * 1997-03-31 2000-04-04 Abbott Laboraties Nutritional formulations containing oligosaccharides

Also Published As

Publication number Publication date
EP1242436A2 (de) 2002-09-25
AU2006201A (en) 2001-06-18
CA2394090C (en) 2010-09-28
PL356238A1 (en) 2004-06-28
HUP0203707A3 (en) 2004-12-28
EP1242436B1 (de) 2004-11-17
MXPA02005491A (es) 2002-09-02
ES2233485T3 (es) 2005-06-16
BR0016161A (pt) 2002-10-29
AU782623B2 (en) 2005-08-18
NZ519706A (en) 2004-03-26
CN1407857A (zh) 2003-04-02
DE19958985A1 (de) 2001-06-13
US7939118B2 (en) 2011-05-10
NO20022688D0 (no) 2002-06-06
HUP0203707A2 (hu) 2003-03-28
JP2003516412A (ja) 2003-05-13
WO2001042263A3 (de) 2001-11-01
US20030129278A1 (en) 2003-07-10
CA2394090A1 (en) 2001-06-14
HK1052438B (zh) 2005-07-08
CZ20021876A3 (cs) 2003-05-14
CZ304817B6 (cs) 2014-11-12
DE50008706D1 (en) 2004-12-23
WO2001042263A2 (de) 2001-06-14
HK1052438A1 (en) 2003-09-19
NO20022688L (no) 2002-06-06
NO330050B1 (no) 2011-02-07
ATE282626T1 (de) 2004-12-15
CN1198624C (zh) 2005-04-27
PT1242436E (pt) 2005-04-29

Similar Documents

Publication Publication Date Title
ATE282626T1 (de) Oligosaccharidmischung
Ehrlich et al. Low back pain initiative
TR200003513T2 (tr) Pirolo[2,3d]Pirimidin kompozisyonları ve kullanımları
HK1033582A1 (en) Antibodies to death receptor 4 (dr4) and uses thereof
BR9814040A (pt) Agudo no pulmão com fibrose com antagonistas de avb6
BR0007027A (pt) Proteìnas pesticidas
DE69533959D1 (de) Retrovirale vektoren, die von gegen lyse durch menschliches serum resistenten produktionszellinien produziert werden
UA48245C2 (uk) ЗАМІЩЕНІ 1,2,3,4-ТЕТРАГІДРО-2-ДИБЕНЗОФУРАНАМІНИ ТА 2-АМІНОЦИКЛОГЕПТА[B]БЕНЗОФУРАНИ, ФАРМАЦЕВТИЧНА ЛІКАРСЬКА ФОРМА ТА СПОСІБ ПІДВИЩЕННЯ АКТИВАЦІЇ 5-НТ<sub>1F</sub> РЕЦЕПТОРА У ССАВЦЯ
BR9609114A (pt) Composição inseticida de terra diatomácea
MD980129A (en) Antiherpetic remedy
DE69729443D1 (de) Modifiziertes pektinmaterial
TAMURA et al. The Validity of the Workload Evaluation by Driver's Subjective Symptoms
Hatcher Managing risk- the way ahead
Kim The methods of drive and approach of standardization
葛宝祥 et al. The Changes in Chinese Educational System From 1964 to 1980s
Carleton " Not one, but... so entwined": man and nature in the early poetry of Yvor Winters
Kriesel Differences of the reconstructed stature in an early Medieval population depending on Pearson's regression equations
El'konin LS Vygotsky and DB El'konin: Sign mediation
Litaay et al. BIVALVES ASSOCIATED WITH LIVING HUMP CORAL, PORITES
RU96102188A (ru) Сбор n 3 лекарственных трав, обладающий общеукрепляющим действием
허원실 et al. Hemicoronal and temporal flap incision combined with intraoral approach for the zygoma fracture
SE9403791L (sv) Skida
清水秀昭 CONNECTIONS OF THE INSULAR CORTEX IN KITTENS: AN ANATOMICALDEMONSTRATION WITH WHEAT GERM AGGLUTININ CONJUGATED TO HORSERADISH PEROXIDASE TECHNIQUE
Bufford Separating the Wheat from the Tares: Evaluating Christian Theories of Personality and Counseling
McGuire Arming Themselves with Information: Veterans Using the Internet